A Startup Has Unlocked a Way to Make Cheap Insulin
Houston-based rBIO has invented a new process
Houston startup completes testing, prepares biosimilar insulin drug for clinical trials
Houston biotech startup is one step closer
rBIO Completes Analytical Characterizations of R-biolin, Readies Biosimilar Insulin Drug for Clinical Trial
rBIO's lead biologic drug, R-biolin, aims to
Houston A Growing Hub for Biotech
The industrial biotechnology industry is one of
California-founded biotech startup relocates to join Houston’s emerging bioeconomy
San Diego-based rBIO moved to Houston to
rBIO Succeeds in Biomanufacturing Insulin
For many Type-1 diabetes patients and the
Scaling insulin production with Cameron Owen, CEO/co-Founder of rBio
Scaling insulin production with Cameron Owen, CEO/co-Founder
rBIO Achieves Crucial Milestone on Mission to Lower the Cost of Insulin by 30%
Just one year after successfully demonstrating lab-scale